TITAN Trial | Investigating the addition of apalutamide to androgen deprivation therapy

Each day around 70 men will be diagnosed with prostate cancer in Australia. For many of these men, there can be a host of treatments available for their healthcare teams to consider. Join us in this latest Prostate Vodcast as the esteemed Dr Axel Merseburger and Katie Clift lead a discussion on the TITAN trial — investigating the addition of apalutamide to androgen deprivation therapy for men with different types of prostate cancer — while looking to address how clinicians decide between available treatment options. To find out more or to access support, reach out to PCFA via 1800 22 00 99 or visit www.prostate.org.au.